Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Main Street Capital Corporation (MAIN) vs Tenet Healthcare Corporation (THC) Price & Performance

Main Street Capital CorporationTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

Main Street Capital Corporation vs Tenet Healthcare Corporation — how do they compare? Main Street Capital Corporation trades at $54.47 (market cap $5.09B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is far larger — about 4.1× Main Street Capital Corporation's market cap, and Main Street Capital Corporation pays a 5.84% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Main Street Capital Corporation for 88 Days and Tenet Healthcare Corporation for 15 Days on average.

MAINTHC
Market Cap
$5.09B$20.98B
Volume
524,060428,008
Sector
FinancialsHealth
52-Week High
$64.60$280.77
52-Week Low
$49.63$161.37
Typical Hold Time
88 Days15 Days
Enterprise Value
$7.54B$32.06B
Dividend Yield
5.84%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Main Street Capital Corporation

MAIN trades at $54.18, down 1.08% on the day, with a bearish technical signal from moving averages and oscillators. The company reported revenue of $592 million and net income of $493 million for 2025, with a net income margin of 83.36%. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1 2026. Analyst consensus is a Hold with a $58.33 price target, indicating modest upside potential.

Outlook: MAIN offers a stable dividend history and strong profitability, but faces headwinds from softening revenue projections for 2026 and negative operating cash flow. Risks include earnings volatility and high valuation multiples. The stock presents a cautious opportunity for income-focused investors, balanced by near-term fundamental pressures.

Tenet Healthcare Corporation

Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.

THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MAIN
13% Buy87% Sell
Avg holding period · 88 Days
THC

No sentiment data available yet.

Top news

Latest headlines on both assets

About Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.

Read more on MAIN →

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC →